|Articles|January 7, 2005
- Pharmaceutical Technology-11-01-2004
- Volume 2004 Supplement
- Issue 8
Named Anchor Problem
Named Anchor Problems
Advertisement
See
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
The Next Generation of Medicine: Personalized, Preventive, and Powered by Technology
4
The FDA Moves to Modernize Drug Manufacturing Registration
5
